Comparative effects of second-line oral antidiabetic medications on atrial fibrillation risk in patients with type 2 diabetes: a nationwide retrospective cohort study
This study showed that SGLT2 inhibitor use was associated with a significantly lower risk of AF than use of thiazolidinediones, DPP-4 inhibitors, and sulfonylureas.
Authors
- Ye Eun Ko (ORCID: https://orcid.org/0009-0002-5369-2031)
- Hee Byung Koh (ORCID: https://orcid.org/0000-0002-4510-2823)
- Ga Young Heo (ORCID: https://orcid.org/0000-0003-0913-5289)
- H. R. Kim
- tae-hyun yoo
- jung tak park
- B M Ko
- Minkyung Han
- Seung Hyeok Han
- Shin-Wook Kang
- Cheol Ho Park
- Seok-Jae Heo
Institutions
- Yonsei University (KR)
- Korea University (KR)
- Yonsei University Health System (KR)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1186/s12933-025-03024-9
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00